P
BMY icon

&Partners’s Bristol-Myers Squibb BMY Stock Holding History

&Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.79M Buy
161,573
+18,733
+13% +$1.09M 0.05% 331
2025
Q4 		$7.71M Buy
142,840
+15,701
+12% +$755K 0.04% 369
2025
Q3 		$5.73M Buy
127,139
+7,060
+6% +$330K 0.04% 388
2025
Q2 		$5.56M Sell
120,079
-23,686
-16% -$1.16M 0.04% 348
2025
Q1 		$8.63M Buy
143,765
+10,722
+8% +$625K 0.09% 211
2024
Q4 		$7.49M Buy
133,043
+40,301
+43% +$2.25M 0.09% 220
2024
Q3 		$4.82M Buy
92,742
+41,662
+82% +$1.95M 0.09% 208
2024
Q2 		$2.12M Buy
51,080
+33,469
+190% +$1.5M 0.09% 206
2024
Q1 		$955K Buy
17,611
+7,616
+76% +$388K 0.13% 159
2023
Q4 		$513K Buy
9,995
+2,652
+36% +$139K 0.13% 153
2023
Q3 		$426K Sell
7,343
-440
-6% -$27K 0.2% 95
2023
Q2 		$498K Sell
7,783
-550
-7% -$36.9K 0.22% 86
2023
Q1 		$578K Sell
8,333
-260
-3% -$18.3K 0.28% 68
2022
Q4 		$618K Sell
8,593
-40
-0.5% -$3.02K 0.31% 66
2022
Q3 		$614K Buy
8,633
+344
+4% +$25K 0.36% 67
2022
Q2 		$631K Buy
8,289
+159
+2% +$12.1K 0.36% 66
2022
Q1 		$594K Buy
8,130
+3,240
+66% +$218K 0.33% 70
2021
Q4 		$305K Sell
4,890
-100
-2% -$5.87K 0.18% 126
2021
Q3 		$295K Buy
4,990
+110
+2% +$7.24K 0.19% 124
2021
Q2 		$326K Buy
4,880
+50
+1% +$3.26K 0.21% 109
2021
Q1 		$305K Buy
4,830
+500
+12% +$31.1K 0.22% 106
2020
Q4 		$293K Buy
4,330
+900
+26% +$55.3K 0.25% 98
2020
Q3 		$243K Sell
3,430
-1,500
-30% -$90.3K 0.25% 97
2020
Q2 		$290K Hold
4,930
– – 0.35% 75
2020
Q1 		$275K Sell
4,930
-500
-9% -$30.6K 0.43% 75
2019
Q4 		$349K Buy
+5,430
New +$311K 0.42% 83

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

&Partners's BMY Position: Q1 2026 in Review

&Partners increased its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, buying an estimated $1.09M and bringing the position to 161,573 shares worth $9.79M. The position accounts for 0.05% of the portfolio, ranked #331.

&Partners first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • &Partners held 161,573 shares of Bristol-Myers Squibb worth $9.79M as of Q1 2026.
  • &Partners bought 18,733 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.09M.
  • Bristol-Myers Squibb made up 0.05% of &Partners's portfolio in Q1 2026, its #331 holding.
  • &Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.